BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37726769)

  • 1. Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss.
    Epah J; Spohn G; Preiß K; Müller MM; Dörr J; Bauer R; Daqiq-Mirdad S; Schwäble J; Bernas SN; Schmidt AH; Seifried E; Schäfer R
    BMC Med; 2023 Sep; 21(1):360. PubMed ID: 37726769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of progenitor cell populations and growth factors after bone marrow aspirate concentration.
    Schäfer R; DeBaun MR; Fleck E; Centeno CJ; Kraft D; Leibacher J; Bieback K; Seifried E; Dragoo JL
    J Transl Med; 2019 Apr; 17(1):115. PubMed ID: 30961655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MarrowMiner: A Novel Minimally Invasive and Effective Device for the Harvest of Bone Marrow.
    Kraft DL; Walck ER; Carrasco A; Crocker MD; Song L; Long MG; Mosse MA; Nadeem B; Imanbayev GT; Czechowicz AD; McCullough MJ
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):219-229. PubMed ID: 31491487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow-Harvesting Technique Influences Functional Heterogeneity of Mesenchymal Stem/Stromal Cells and Cartilage Regeneration.
    Sivasubramaniyan K; Ilas DC; Harichandan A; Bos PK; Santos DL; de Zwart P; Koevoet WJLM; Owston H; Bühring HJ; Jones E; van Osch GJVM
    Am J Sports Med; 2018 Dec; 46(14):3521-3531. PubMed ID: 30419181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopsy Needle Advancement during Bone Marrow Aspiration Increases Mesenchymal Stem Cell Concentration.
    Peters AE; Watts AE
    Front Vet Sci; 2016; 3():23. PubMed ID: 27014705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-CSF treatment of healthy pediatric donors affects their hematopoietic microenvironment through changes in bone marrow plasma cytokines and stromal cells.
    Aerts-Kaya F; Kilic E; Köse S; Aydin G; Cagnan I; Kuskonmaz B; Uckan-Cetinkaya D
    Cytokine; 2021 Mar; 139():155407. PubMed ID: 33383380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bone marrow aspiration strategy on the yield and quality of human mesenchymal stem cells.
    Fennema EM; Renard AJ; Leusink A; van Blitterswijk CA; de Boer J
    Acta Orthop; 2009 Oct; 80(5):618-21. PubMed ID: 19916699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells.
    Hernigou P; Homma Y; Flouzat Lachaniette CH; Poignard A; Allain J; Chevallier N; Rouard H
    Int Orthop; 2013 Nov; 37(11):2279-87. PubMed ID: 23881064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.
    Prokopishyn NL; Logan BR; Kiefer DM; Sees JA; Chitphakdithai P; Ahmed IA; Anderlini PN; Beitinjaneh AM; Bredeson C; Cerny J; Chhabra S; Daly A; Diaz MA; Farhadfar N; Frangoul HA; Ganguly S; Gastineau DA; Gergis U; Hale GA; Hematti P; Kamble RT; Kasow KA; Lazarus HM; Liesveld JL; Murthy HS; Norkin M; Olsson RF; Papari M; Savani BN; Szer J; Waller EK; Wirk B; Yared JA; Pulsipher MA; Shah NN; Switzer GE; O'Donnell PV; Confer DL; Shaw BE
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1325-1330. PubMed ID: 30716454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use.
    Cuthbert R; Boxall SA; Tan HB; Giannoudis PV; McGonagle D; Jones E
    Cytotherapy; 2012 Apr; 14(4):431-40. PubMed ID: 22268519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived from the human femoral shaft as a new source of mesenchymal stem/stromal cells: an alternative cell material for banking and clinical transplantation.
    Drela K; Stanaszek L; Snioch K; Kuczynska Z; Wrobel M; Sarzynska S; Legosz P; Maldyk P; Lukomska B
    Stem Cell Res Ther; 2020 Jun; 11(1):262. PubMed ID: 32605638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity.
    Crippa S; Rossella V; Aprile A; Silvestri L; Rivis S; Scaramuzza S; Pirroni S; Avanzini MA; Basso-Ricci L; Hernandez RJ; Zecca M; Marktel S; Ciceri F; Aiuti A; Ferrari G; Bernardo ME
    J Clin Invest; 2019 Feb; 129(4):1566-1580. PubMed ID: 30830876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure.
    Cassens U; Ostkamp-Ostermann P; Garritsen H; Kelsch R; Ostermann H; Kienast J; Kiehl M; Buechner T; van de Loo J; Juergens H; Sibrowski W
    Bone Marrow Transplant; 1997 Apr; 19(8):835-40. PubMed ID: 9134178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
    Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
    Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramyocardial bone marrow mononuclear cells versus bone marrow-derived and adipose mesenchymal cells in a rat model of dilated cardiomyopathy.
    Carmona MD; Cañadillas S; Romero M; Blanco A; Nogueras S; Herrera C
    Cytotherapy; 2017 Aug; 19(8):947-961. PubMed ID: 28673775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor age effects on in vitro chondrogenic and osteogenic differentiation performance of equine bone marrow- and adipose tissue-derived mesenchymal stromal cells.
    Bagge J; Berg LC; Janes J; MacLeod JN
    BMC Vet Res; 2022 Nov; 18(1):388. PubMed ID: 36329434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34
    Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
    Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.